Tadahiro Gunji

Minato, 1050003, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Journal: International journal of clinical oncology

Published: April 11, 2026

Status Epilepticus as the Initial Manifestation of Follicular Lymphoma with Leptomeningeal Dissemination.

Status Epilepticus as the Initial Manifestation of Follicular Lymphoma with Leptomeningeal Dissemination.

Journal: Internal medicine (Tokyo, Japan)

Published: February 01, 2026

Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.

Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.

Journal: Japanese journal of clinical oncology

Published: December 16, 2025

Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registry.

Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registry.

Journal: European heart journal open

Published: September 23, 2025

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Journal: International journal of hematology

Published: August 09, 2025

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Journal: Cancers

Published: November 27, 2024

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Journal: International journal of hematology

Published: September 06, 2024

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Journal: Cancer diagnosis & prognosis

Published: August 15, 2024

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Journal: International journal of hematology

Published: August 06, 2024

Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.

Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.

Journal: Internal medicine (Tokyo, Japan)

Published: August 09, 2023

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Journal: International journal of hematology

Published: July 25, 2023

A rare case of Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis.

A rare case of Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis.

Journal: Clinical journal of gastroenterology

Published: November 23, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026